Oral antineoplastic agents: how do we care about adherence?

Por Barillet, Marie, Prevost, Virginie, Joly, Florence, Clarisse, Bénédicte
Publicado no Br J Clin Pharmacol (2015)

Evidence for the Presence of Insulin-Dependent Diabetes-Associated Alleles on the Distal Part of Mouse Chromosome 6

Por Melanitou, Evie, Joly, Florence, Lathrop, Mark, Boitard, Christian, Avner, Philip
Publicado em 1998

Biomarkers Associated with Cognitive Impairment in Treated Cancer Patients: Potential Predisposition and Risk Factors

Por Castel, Hélène, Denouel, Angeline, Lange, Marie, Tonon, Marie-Christine, Dubois, Martine, Joly, Florence
Publicado no Front Pharmacol (2017)

Skeletal muscle alterations and exercise performance decrease in erythropoietin-deficient mice: a comparative study

Por Mille-Hamard, Laurence, Billat, Veronique L, Henry, Elodie, Bonnamy, Blandine, Joly, Florence, Benech, Philippe, Barrey, Eric
Publicado em 2012

Predictive factors of (18)F-choline PET/CT positivity in patients with prostate cancer recurrence after radiation therapy: is the impact of PSA nadir underestimated?

Por Johnson, Alison C., Dugué, Audrey Emmanuelle, Silva, Marlon, Moise, Laura, Tillou, Xavier, Joly, Florence, Aide, Nicolas
Publicado no EJNMMI Res (2016)

Cross-cultural adaptation and validation of the French version of the Expanded Prostate cancer Index Composite questionnaire for health-related quality of life in prostate cancer p...

Por Anota, Amélie, Mariet, Anne-Sophie, Maingon, Philippe, Joly, Florence, Bosset, Jean-François, Guizard, Anne-Valérie, Bittard, Hugues, Velten, Michel, Mercier, Mariette
Publicado no Health Qual Life Outcomes (2016)

Evaluation of the Impact of the Cancer Therapy Everolimus on the Central Nervous System in Mice

Por Dubois, Martine, Le Joncour, Vadim, Tonon, Marie-Christine, Anouar, Youssef, Proust, François, Morin, Fabrice, Gandolfo, Pierrick, Joly, Florence, Hilber, Pascal, Castel, Hélène
Publicado no PLoS One (2014)

Gene expression analysis reveals early changes in several molecular pathways in cerebral malaria-susceptible mice versus cerebral malaria-resistant mice

Por Delahaye, Nicolas F, Coltel, Nicolas, Puthier, Denis, Barbier, Mathieu, Benech, Philippe, Joly, Florence, Iraqi, Fuad A, Grau, Georges E, Nguyen, Catherine, Rihet, Pascal
Publicado em 2007

A phase II study of afatinib, an irreversible ErbB family blocker, added to letrozole in patients with estrogen receptor-positive hormone-refractory metastatic breast cancer progre...

Por Gunzer, Katharina, Joly, Florence, Ferrero, Jean-Marc, Gligorov, Joseph, de Mont-Serrat, Helene, Uttenreuther-Fischer, Martina, Pelling, Katy, Wind, Sven, Bousquet, Guilhem, Misset, Jean-Louis
Publicado no Springerplus (2016)

A Phase II Trial Evaluating the Efficacy and Safety of Efavirenz in Metastatic Castration-Resistant Prostate Cancer

Por Houédé, Nadine, Pulido, Marina, Mourey, Loic, Joly, Florence, Ferrero, Jean-Marc, Bellera, Carine, Priou, Frank, Lalet, Caroline, Laroche-Clary, Audrey, Raffin, Mireille Canal, Ichas, François, Puech, Alain, Piazza, Pierre Vincenzo
Publicado no Oncologist (2014)

A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER Study

Por Diéras, Véronique, Bachelot, Thomas, Campone, Mario, Isambert, Nicolas, Joly, Florence, Le Tourneau, Christophe, Cassier, Philippe, Bompas, Emmanuelle, Fumoleau, Pierre, Noal, Sabine, Orsini, Christine, Jimenez, Marta, Imbs, Diane Charlotte, Chatelut, Etienne
Publicado no Oncol Ther (2016)

Decline in Cognitive Function in Older Adults With Early-Stage Breast Cancer After Adjuvant Treatment

Por Lange, Marie, Heutte, Natacha, Rigal, Olivier, Noal, Sabine, Kurtz, Jean-Emmanuel, Lévy, Christelle, Allouache, Djelila, Rieux, Chantal, Lefel, Johan, Clarisse, Bénédicte, Veyret, Corinne, Barthélémy, Philippe, Longato, Nadine, Castel, Hélène, Eustache, Francis, Giffard, Bénédicte, Joly, Florence
Publicado no Oncologist (2016)

Patient-Reported Outcome Results From the Open-Label Phase III AURELIA Trial Evaluating Bevacizumab-Containing Therapy for Platinum-Resistant Ovarian Cancer

Por Stockler, Martin R., Hilpert, Felix, Friedlander, Michael, King, Madeleine T., Wenzel, Lari, Lee, Chee Khoon, Joly, Florence, de Gregorio, Nikolaus, Arranz, José Angel, Mirza, Mansoor Raza, Sorio, Roberto, Freudensprung, Ulrich, Sneller, Vesna, Hales, Gill, Pujade-Lauraine, Eric
Publicado no J Clin Oncol (2014)

Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B Study

Por Oza, Amit M., Selle, Frédéric, Davidenko, Irina, Korach, Jacob, Mendiola, Cesar, Pautier, Patricia, Chmielowska, Ewa, Bamias, Aristotelis, DeCensi, Andrea, Zvirbule, Zanete, González-Martín, Antonio, Hegg, Roberto, Joly, Florence, Zamagni, Claudio, Gadducci, Angiolo, Martin, Nicolas, Robb, Stephen, Colombo, Nicoletta
Publicado no Int J Gynecol Cancer (2017)

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

Por Oza, Amit M, Cook, Adrian D, Pfisterer, Jacobus, Embleton, Andrew, Ledermann, Jonathan A, Pujade-Lauraine, Eric, Kristensen, Gunnar, Carey, Mark S, Beale, Philip, Cervantes, Andrés, Park-Simon, Tjoung-Won, Rustin, Gordon, Joly, Florence, Mirza, Mansoor R, Plante, Marie, Quinn, Michael, Poveda, Andrés, Jayson, Gordon C, Stark, Dan, Swart, Ann Marie, Farrelly, Laura, Kaplan, Richard, Parmar, Mahesh K B, Perren, Timothy J
Publicado no Lancet Oncol (2015)